Trending Similar Videos
Drug pricing initiatives during the Trump presidency
Tom Bulleit, Ropes & Gray health care partner, discusses the Trump Administration’s latest drug pricing initiatives.
DOJ enforcement update: electronic health records
Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, provides an update on the enforcement of electronic health records by the Department of Justice (DOJ).
Section 101: confusion over patentable subject matter
Matt Rizzolo, Ropes & Gray IP litigation partner, addresses the ongoing confusion over what constitutes patentable subject matter under Section 101 of the Patent Act.
Behavioral sciences approach to risk management
Amanda Raad, co-chair of Ropes & Gray’s anti-corruption & international risk practice, discusses the new data-driven behavioral sciences approach to risk management.
Trade secret litigation after the Defend Trade Secrets Act
Peter Brody, Ropes & Gray IP litigation partner, discusses the Defend Trade Secrets Act (DTSA) and how it has changed the trade secret litigation landscape since it was enacted in 2016.
False Claims Act: three years after Escobar
Kirsten Mayer, Ropes & Gray litigation partner, provides an update on the False Claims Act (FCA), three years after the Supreme Court’s decision on Universal Health Services v. U.S. ex rel. Escobar.